Literature DB >> 30366559

Neurocysticercosis.

Hector H Garcia1.   

Abstract

Neurocysticercosis (NCC) is a major contributor to the burden of seizure disorders and epilepsy in most of the world. NCC encompasses a variety of clinical presentations, depending on number, location, size, evolutionary stage of lesions, and the inflammatory response of the host, with late-onset seizures, headache, and intracranial hypertension the most frequent manifestations. Diagnosis and therapy depend on the type of NCC, considering its location and stage of the lesions. Medical therapy for NCC should be oriented to obtain appropriate symptom control and then use of antiparasitic agents considered. Antiparasitic treatment is of benefit in most cases of viable and degenerating NCC.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Albendazole; Cysticercosis; Epilepsy; Nervous system infections; Neurocysticercosis; Praziquantel; Taenia solium

Mesh:

Substances:

Year:  2018        PMID: 30366559     DOI: 10.1016/j.ncl.2018.07.003

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  17 in total

1.  Surgical case of subacute headache in a young Latin American woman.

Authors:  Rina Di Bonaventura; Quintino Giorgio D'Alessandris; Liverana Lauretti
Journal:  BMJ Case Rep       Date:  2019-04-24

2.  Cerebral Cysticercosis Presenting With Recurrent Epileptic Seizures.

Authors:  Pham Hong Van; Nguyen Quang Thieu; Cao Ba Loi; Ngo Minh Xuan; Huynh Quang Huy
Journal:  Cureus       Date:  2020-05-16

3.  Molecular characterization of the serotonergic transporter from the cestode Echinococcus granulosus: pharmacology and potential role in the nervous system.

Authors:  Federico Camicia; Hugo R Vaca; Ines Guarnaschelli; Uriel Koziol; Ole V Mortensen; Andreia C K Fontana
Journal:  Parasitol Res       Date:  2022-02-16       Impact factor: 2.383

4.  Cases of Neuroinfectious Disease Highlighting Frontotemporal Neurocircuitry in Cognitive and Affective Processing.

Authors:  Michael D Kritzer; Karen Buch; Shibani S Mukerji; Alessandro Biffi; Zeina Chemali
Journal:  Prim Care Companion CNS Disord       Date:  2021-11-04

5.  Neurocysticercosis control for primary epilepsy prevention: a systematic review.

Authors:  Zhe Wang; Roxanna M Garcia; Hanalise V Huff; Milagros Niquen-Jimenez; Luis A Marcos; Sandi K Lam
Journal:  Pathog Glob Health       Date:  2021-12-20       Impact factor: 3.735

6.  Frequency and Determinant Factors for Calcification in Neurocysticercosis.

Authors:  Javier A Bustos; Gianfranco Arroyo; Robert H Gilman; Percy Soto-Becerra; Isidro Gonzales; Herbert Saavedra; E Javier Pretell; Theodore E Nash; Seth E O'Neal; Oscar H Del Brutto; Armando E Gonzalez; Hector H Garcia
Journal:  Clin Infect Dis       Date:  2021-11-02       Impact factor: 20.999

7.  Cerebellar Neurocysticercosis as Long-Term Complication of Allogeneic Haematopoietic Stem Cell Transplantation from Haploidentical Donor.

Authors:  Federico Meconi; Giulia Ciangola; Benedetta Mariotti; Raffaella Cerretti; Laura Cudillo; William Arcese; Alessandra Picardi
Journal:  Case Rep Infect Dis       Date:  2019-09-19

8.  Further evaluation of recombinant Tsol-p27 by enzyme-linked immunoelectrotransfer blot for the serodiagnosis of cysticercosis in pigs from Mozambique.

Authors:  Noemia Nhancupe; Emilia V Noormahomed; Sonia Afonso; Staffan Svard; Johan Lindh
Journal:  Parasit Vectors       Date:  2019-11-27       Impact factor: 3.876

9.  Impact of a 3-year mass drug administration pilot project for taeniasis control in Madagascar.

Authors:  Noromanana Sylvia Ramiandrasoa; Pascaline Ravoniarimbinina; Armand Rafalimanantsoa Solofoniaina; Iharilanto Patricia Andrianjafy Rakotomanga; Samuel Hermas Andrianarisoa; Sophie Molia; Anne-Marie Labouche; Anna Sophie Fahrion; Meritxell Donadeu; Bernadette Abela-Ridder; Davidra Rajaonatahina
Journal:  PLoS Negl Trop Dis       Date:  2020-09-18

10.  High frequency of Taenia solium antigen positivity in patients admitted for neurological disorders in the Rural Hospital of Mosango, Democratic Republic of Congo.

Authors:  Deby Mukendi; Jean-Roger Lilo Kalo; Pascal Lutumba; Barbara Barbé; Jan Jacobs; Cedric P Yansouni; Sarah Gabriël; Pierre Dorny; François Chappuis; Marleen Boelaert; Andrea S Winkler; Kristien Verdonck; Emmanuel Bottieau
Journal:  BMC Infect Dis       Date:  2021-04-17       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.